Australia (AU)

TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer (2017) Fagerholm R, Khan S, Schmidt MK, Garcia-Closas M, Heikkila P, Saarela J, Beesley J, et al. Journal article Impaired Response Selection During Stepping Predicts Falls in Older People-A Cohort Study (2017) Schöne D, Delbaere K, Lord SR Journal article Expression of Membrane-Bound CC Chemokine Ligand 20 on Follicular T Helper Cells in T-B-Cell Conjugates (2017) Lee AYS, Reimer D, Zehrer A, Lu M, Mielenz D, Korner H Journal article Early CCR6 expression on B cells modulates germinal centre kinetics and efficient antibody responses (2017) Reimer D, Lee AYS, Bannan J, Fromm P, Kara EE, Comerford I, Mccoll S, et al. Journal article Comparison between clinical gait and daily-life gait assessments of fall risk in older people (2017) Brodie MA, Coppens MJ, Ejupi A, Gschwind YJ, Annegarn J, Schöne D, Wieching R, et al. Journal article Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study (2017) Jones D, Boudes PF, Swain MG, Bowlus CL, Galambos MR, Bacon BR, Doerffel Y, et al. Journal article Renaming all spinal autonomic outflows as sympathetic is a mistake (2017) Jaenig W, Keast JR, Mclachlan EM, Neuhuber W, Southard-Smith M Journal article The Sacral Autonomic Outflow Is Spinal, but Not "Sympathetic" (2017) Neuhuber W, Mclachlan E, Jaenig W Journal article SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN THE SIGNS AND SYMPTOMS OF ACTIVE PSORIATIC ARTHRITIS: 3-YEAR EFFICACY AND SAFETY RESULTS FROM PHASE 3 FUTURE 1 TRIAL (2017) Mease PJ, Kavanaugh A, Reimold A, Tahir H, Rech J, Hall S, Geusens P, et al. Conference contribution SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN THE SIGNS AND SYMPTOMS OF ACTIVE PSORIATIC ARTHRITIS (PSA) THROUGH 3 YEARS: EFFICACY AND SAFETY RESULTS FROM A PHASE 3 TRIAL (2017) Hall S, Mease P, Kavanaugh A, Reimold A, Tahir H, Rech J, Geusens P, et al. Conference contribution